Literature DB >> 12110760

Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.

M H Lequin1, I M van der Shuis, R R Van Rijn, W C J Hop, M M van ven Huevel-Eibrink, S M P F MuinckKeizer-Schrama, C van Kuijk.   

Abstract

Acute lymphoblastic leukemia (ALL) in childhood is a serious disease that can affect growth and the attainment of maximal peak bone mass. The latter has recently been recognized as a risk factor for the development of osteoporosis later in life. To determine long-term effects of the disease itself and its treatment, we assessed the bone status of a group of long-term survivors of childhood ALL, all treated with high doses of steroids (dexamethasone) and methotrexate and without cranial irradiation. All 21 subjects enrolled in this cross-sectional study were diagnosed to have non-high-risk precursors acute lymphoblastic leukemia (12 boys and 9 girls, mean age 16.5 yr, range 12.2-25.4 yr). Standard deviation (SD) scores were calculated using a tibial ultrasound device and spinal dual-energy X-ray absorptiometry (DXA) device as bone assessment techniques. SD scores of those two different bone assessment techniques were compared. The mean SOS (speed of sound) SD scores (SDS) of the tibia (mean 0.26, standard deviation [sd] 1.00) were not significantly different from our reference value of 0. There was no significant difference between the SOS SDS in boys and girls. With DXA, no significant difference was seen between the mean BMD SDS and the reference data and no significant difference in BMD between boys and girls was found. The individual mean SDS for bone mineral density (BMD) of lumbar spine are 0.24 (sd 1.02), total body 0.17 (sd 1.00), and apparent BMD (BMAD) 0.07 (sd 1.09). Spearman's correlation between mean SOS SDS and mean BMD of lumbar spine was 0.47, mean SOS SDS and mean BMAD SDS was 0.43, and mean SOS SDS and mean BMD of total body was 0.49. These correlations were significant at the 0.05 level (two tailed). Despite high-dose dexamethasone and methotrexate used for treatment of these children with ALL, no long-term side effects on the bone mineral status of the subjects, measured with DXA or tibial ultrasonometry, could be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110760     DOI: 10.1385/jcd:5:2:167

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  9 in total

Review 1.  Evidence-based outcomes on diagnostic accuracy of quantitative ultrasound for assessment of pediatric osteoporosis - a systematic review.

Authors:  Kuan Chung Wang; Kuan Chieh Wang; Afsaneh Amirabadi; Edward Cheung; Elizabeth Uleryk; Rahim Moineddin; Andrea S Doria
Journal:  Pediatr Radiol       Date:  2014-06-25

2.  Bone mineral density in young adult survivors of acute lymphoblastic leukemia.

Authors:  Inas H Thomas; Janet E Donohue; Kirsten K Ness; Donald R Dengel; K Scott Baker; James G Gurney
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

Review 3.  Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods.

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-02-12

4.  Prediction of Low and Very Low Bone Mineral Density Among Adult Survivors of Childhood Cancer.

Authors:  Jenneke E van Atteveld; Saskia M F Pluijm; Kirsten K Ness; Melissa M Hudson; Wassim Chemaitilly; Sue C Kaste; Leslie L Robison; Sebastian J C M M Neggers; Yutaka Yasui; Marry M van den Heuvel-Eibrink; Carmen L Wilson
Journal:  J Clin Oncol       Date:  2019-05-31       Impact factor: 50.717

5.  Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.

Authors:  Pakize Karakaya; Sebnem Yılmaz; Ozlem Tüfekçi; Mustafa Kır; Ece Böber; Gülersu Irken; Hale Oren
Journal:  Turk J Haematol       Date:  2013-09-05       Impact factor: 1.831

6.  Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia

Authors:  Farzaneh Rohani; Khadijeh Arjmandi Rafsanjani; Gholamreza Bahoush; Mansoureh Sabzehparvar; Mohammad Ahmadi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

7.  Late effects of high-dose methotrexate treatment in childhood cancer survivors-a systematic review.

Authors:  Maria Otth; Katrin Scheinemann; Eveline Daetwyler; Mario Bargetzi
Journal:  BMC Cancer       Date:  2022-03-14       Impact factor: 4.430

8.  Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.

Authors:  Tristan J King; Tetyana Shandala; Alice M Lee; Bruce K Foster; Ke-Ming Chen; Peter R Howe; Cory J Xian
Journal:  Int J Mol Sci       Date:  2015-08-06       Impact factor: 5.923

9.  Factors related to decreased bone mineral density in childhood cancer survivors.

Authors:  Yun Jung Choi; Sun Young Park; Won Kyoung Cho; Jae Wook Lee; Kyoung Soon Cho; So Hyun Park; Seung Hoon Hahn; Min Ho Jung; Nack Gyun Chung; Bin Cho; Byung Kyu Suh; Hack Ki Kim
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.